What is the official website of PHOENIX Farmacija ?

The official website of PHOENIX Farmacija is http://www.phoenix-farmacija.hr.

What is PHOENIX Farmacija's cybersecurity risk score?

PHOENIX Farmacija has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has PHOENIX Farmacija experienced?

According to Rankiteo, PHOENIX Farmacija currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has PHOENIX Farmacija been affected by any supply chain cyber incidents ?

According to Rankiteo, PHOENIX Farmacija has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does PHOENIX Farmacija have SOC 2 Type 1 certification ?

According to Rankiteo, PHOENIX Farmacija is not certified under SOC 2 Type 1.

Does PHOENIX Farmacija have SOC 2 Type 2 certification ?

According to Rankiteo, PHOENIX Farmacija does not hold a SOC 2 Type 2 certification.

Does PHOENIX Farmacija comply with GDPR ?

According to Rankiteo, PHOENIX Farmacija is not listed as GDPR compliant.

Does PHOENIX Farmacija have PCI DSS certification ?

According to Rankiteo, PHOENIX Farmacija does not currently maintain PCI DSS compliance.

Does PHOENIX Farmacija comply with HIPAA ?

According to Rankiteo, PHOENIX Farmacija is not compliant with HIPAA regulations.

Does PHOENIX Farmacija have ISO 27001 certification ?

According to Rankiteo,PHOENIX Farmacija is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does PHOENIX Farmacija operate in ?

PHOENIX Farmacija operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does PHOENIX Farmacija have ?

PHOENIX Farmacija employs approximately 165 people worldwide.

Does PHOENIX Farmacija own any subsidiaries ?

PHOENIX Farmacija presently has no subsidiaries across any sectors.

How many LinkedIn followers does PHOENIX Farmacija have ?

PHOENIX Farmacija's official LinkedIn profile has approximately 5,525 followers.

What is the NAICS classification code for PHOENIX Farmacija ?

PHOENIX Farmacija is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does PHOENIX Farmacija have a Crunchbase profile ?

No, PHOENIX Farmacija does not have a profile on Crunchbase.

Does PHOENIX Farmacija have a LinkedIn profile ?

Yes, PHOENIX Farmacija maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/phoenix-farmacija.

How many cybersecurity incidents has PHOENIX Farmacija experienced ?

As of October 12, 2026, Rankiteo reports that PHOENIX Farmacija has not experienced any cybersecurity incidents.

How many peer or competitor companies does PHOENIX Farmacija have ?

PHOENIX Farmacija has an estimated 5,774 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

PHOENIX Farmacija

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

PHOENIX Farmacija Vendor Cyber Rating & Cyber Score

phoenix-farmacija.hr

Add Your Compliance Badge

PHOENIX Farmacija, one of the leading pharmaceutical wholesalers in Croatia, is a member of the PHOENIX Group, a leading European pharmaceutical wholesaler. The company ensures the supply of drugs and medical products to a number of subjects in the healthcare system: pharmacies, hospitals, health centres, and medical diagnostic laboratories. The company was established in 2004 after the merger of Medifarm-Velebit d.d. and Farmacija d.d. owned by PHOENIX. Today PHOENIX Farmacija’s market share in Croatia is around 24%. The company has five distribution centres: Zagreb (where the company is headquartered), Velika Gorica, Osijek, Rijeka and Solin. The company has the total of 320 employees. In addition to drugs, food supplements and

PHOENIX Farmacija

PHOENIX Farmacija CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

PHOENIX Farmacija Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for PHOENIX Farmacija

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for PHOENIX Farmacija in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for PHOENIX Farmacija in 2026.

Incident Types PHOENIX Farmacija vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for PHOENIX Farmacija in 2026.

Incident History - PHOENIX Farmacija (X = Date, Y = Severity)

Loading…

SUBSIDIARY

PHOENIX Farmacija Subsidiaries

PHOENIX Farmacija

Pharmaceutical Manufacturing

Website: http://www.phoenix-farmacija.hr

Company Size: 165

PHOENIX group - Integrated Healthcare ProviderWholesale

Help Net FarmaPharmaceutical Manufacturing

NomecoTransportation, Logistics, Supply Chain and Storage

Gruppo ComifarTransportation, Logistics, Supply Chain and Storage

FarmeximWholesale Drugs and Sundries

PHOENIX Medical Supplies LtdPharmaceutical Manufacturing

Tamro FinlandWholesale

SmilaHospitals and Health Care

PHX IrelandPharmaceutical Manufacturing

BENUPharmaceutical Manufacturing

Pharmacies BENU SAPharmaceutical Manufacturing

Loading…

PHOENIX Farmacija Similar Companies

Parexel

parexel.com

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Servier

servier.com

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle. As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D. Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Loading…

NEWS

PHOENIX Farmacija CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-108773

SUMMARY

A vulnerability was detected in erzhongxmu JEEWMS up to 2026.09.27-W39. Impacted is the function docheck of the file src/main/java/com/zzjee/wm/controller/WmOmNoticeHController.java. Performing a manipulation of the argument goodscode results in sql injection. The attack may be initiated remotely. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-10-11

Updated

Date2026-10-11

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-108772

SUMMARY

A security vulnerability has been detected in bleenco abstruse up to 2.1.0. This issue affects the function filepath.Join of the file server/api/worker/download_cache.go of the component Cache Endpoint. Such manipulation of the argument File leads to path traversal. The attack can be launched remotely. The exploit has been disclosed publicly and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-10-11

Updated

Date2026-10-11

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-108770

SUMMARY

A weakness has been identified in Appwrite up to 2.3.0. This vulnerability affects the function PublicHostname of the file src/Appwrite/Platform/Modules/Avatars/Http/Screenshots/Get.php of the component Browser Screenshot Service. This manipulation of the argument url causes server-side request forgery. The attack can be initiated remotely. Upgrading to version 2.4.0 is able to resolve this issue. Patch name: 393255e7302ae5503331d45802e2eee01c6a47fe. You should upgrade the affected component.

Published

Date2026-10-11

Updated

Date2026-10-11

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-108978

SUMMARY

Heap-based buffer overflow vulnerability in Samsung Opensource rlottie allows Buffer Overflow via Environment Variables. This issue affects rlottie: e57b094f03c39a751a1fded6f7d6c13f1ed95ec9.

Published

Date2026-10-11

Updated

Date2026-10-11

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

1.8

REFERENCES

https://github.com/Samsung/rlottie/pull/609/

CVE-2026-108769

SUMMARY

A security flaw has been discovered in zhayujie CowAgent up to 2.2.0. This affects an unknown part of the file Markdown.tsx of the component Markdown Rendering. The manipulation results in denial of service. It is possible to launch the attack remotely. The exploit has been released to the public and may be used for attacks. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-10-11

Updated

Date2026-10-11

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:N/I:N/A:P

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

PHOENIX Farmacija Vendor Cyber Rating & Cyber Score

PHOENIX Farmacija A.I CyberSecurity Scoring

PHOENIX Farmacija CyberSecurity News & History

PHOENIX Farmacija Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for PHOENIX Farmacija

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types PHOENIX Farmacija vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - PHOENIX Farmacija (X = Date, Y = Severity)

PHOENIX Farmacija Subsidiaries

PHOENIX Farmacija

PHOENIX Farmacija Similar Companies

Parexel

Zydus Group

Bristol Myers Squibb

Servier

Alembic Pharmaceuticals Limited

Glenmark Pharmaceuticals

AUROBINDO PHARMA LTD

Merck

Dr. Reddy's Laboratories

PHOENIX Farmacija CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

PHOENIX Farmacija CyberSecurity News & History

PHOENIX Farmacija Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for PHOENIX Farmacija

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types PHOENIX Farmacija vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - PHOENIX Farmacija (X = Date, Y = Severity)

PHOENIX Farmacija Subsidiaries

PHOENIX Farmacija

PHOENIX Farmacija Similar Companies

Parexel

Zydus Group

Bristol Myers Squibb

Servier

Alembic Pharmaceuticals Limited

Glenmark Pharmaceuticals

AUROBINDO PHARMA LTD

Merck

Dr. Reddy's Laboratories

PHOENIX Farmacija CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo